Gilde Healthcare exits occupational health provider BlijWerkt to Mentha Capital - Gilde Healthcare

Gilde Healthcare exits occupational health provider BlijWerkt to Mentha Capital

December 18, 2019

Utrecht (the Netherlands) – Gilde Healthcare today announced it has sold its majority stake in occupational health provider BlijWerkt to Mentha Capital, subject to approval by the Dutch Healthcare Authority. Led by Gilde, BlijWerkt has become a national player and challenger to the established occupational health providers. The successful growth of the company is the result of a differentiating proactive approach and expansion through acquisitions.

BlijWerkt is a fast-growing occupation health provider. Supporting both large organizations and SMEs in managing absenteeism by improving the vitality of organizations and their employees. BlijWerkt manages the process of employee sick leave and return to work.

Gilde Healthcare played an active role in the expansion of the company through the acquisition and integration of other occupational health providers such as Metaplanning, Re-on, Tredin and Immediator. “Gilde Healthcare is well entrenched in the healthcare market and has actively supported our growth trajectory. In a few years we have grown from a local SME service provider to a national player with large clients in our portfolio,” says Ruud Pels, director of BlijWerkt.

Gilde Healthcare reflects positively on its collaboration with BlijWerkt: “as a sector specialist with an active growth strategy, we have been able to add a lot of value,” says Hugo de Bruin, partner at Gilde Healthcare, “by investing in quality of service and the expansion of BlijWerkt towards a national player, we have created an alternative to the large incumbents. This is beneficial for both employees and employers.”

After the acquisition, BlijWerkt will collaborate with the paraDIGMA group. “By joining forces, paraDIGMA and BlijWerkt can further improve the quality and service to its customers and lay a solid foundation for further growth,” said Barend Rutten, partner at Mentha Capital.

In the sale of BlijWerkt, Oaklins acted as the exclusive M&A advisor to the sellers and Jacoline Gortzak, Legaltree, as the legal advisor.

About Gilde Healthcare

Gilde Healthcare is a specialized European healthcare investor managing € 1 billion ($ 1.2 billion) across two fund strategies: private equity and venture & growth capital. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America.
www.gildehealthcare.com

About BlijWerkt

BlijWerkt is the health and safety service that combines the power of the bigger players with the flexibility and personal attention of smaller players. With 120 staff, we are known as a vibrant leader, energizing employers and employees alike.
www.blijwerkt.nl

About Mentha Capital

Mentha Capital is an independent investment company that focuses on the lower-end of the mid-market in the Benelux. Mentha invests in established, medium-sized and profitable companies that have the opportunity to grow further through a buy-and-build strategy, expansion into new markets or an organizational transition. With more than EUR 400 million under management, Mentha works actively with entrepreneurs to support their companies in realizing their ambitious growth plans.
www.menthacapital.com

Gilde Healthcare company NIZO acquires lactic acid facility and strengthens partnership with DSM-firmenich

NIZO food research B.V. (“NIZO”) is proud to announce the signature of a long-term contract manufacturing partnership with dsm-firmenich. This strategic alliance encompasses the acquisition of the neighboring lactic acid facility from Vika Nutrition B.V.,...
February 29, 2024

Gilde Healthcare co-leads oversubscribed €54 Million Series B round of Argá Medtech

Argá Medtech, a company developing a next-generation cardiac ablation system for treating cardiac arrhythmias, including atrial fibrillation (AF), announced it closed a €54M oversubscribed Series B raise co-led by Gilde Healthcare with existing investors, Advent...
February 28, 2024

Gilde Healthcare leads $125 Million Equity Financing of Mainstay Medical

Funding to accelerate commercial growth and expand clinical and health economic evidence for ReActiv8® Restorative NeuromodulationTM System Mainstay Medical Holdings plc today announced an equity financing in which it will receive gross proceeds of US$125...
February 27, 2024